{"text": ["European Commission Approves Amgen's BLINCYTO\u00ae (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia"], "created_at": "Mon, 23 Nov 2015 08:00:00 GMT"}
